T&R Biofab Co., Ltd. (KOSDAQ: 246710)

T&R Biofab Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	15,232	20,228	35,122	23,664	23,279	4,724
Short-Term Investments	-	22,000	101.83	34,501	13,600	17,000
Trading Asset Securities	8,001	9,519	5,199	-	-	-
Cash & Short-Term Investments	23,233	51,747	40,423	58,166	36,879	21,724
Cash Growth	-58.24%	28.01%	-30.50%	57.72%	69.76%	-24.65%
Accounts Receivable	23.67	1,476	1,228	975.42	563.54	156.8
Other Receivables	-	612.79	702.59	427.46	597.67	381.2
Receivables	23.67	2,088	1,931	1,403	1,161	538
Inventory	3,296	2,478	2,840	3,476	3,579	424.42
Prepaid Expenses	-	374	412.33	140.69	148.35	79.88
Other Current Assets	6,866	871.45	1,229	8,121	1,067	111.15
Total Current Assets	33,419	57,558	46,835	71,306	42,834	22,877
Property, Plant & Equipment	35,271	34,836	20,287	10,996	2,616	1,893
Long-Term Investments	2,247	2,996	4,299	3,396	700	557.17
Other Intangible Assets	919.01	831.24	850.36	804.07	719.78	333.32
Other Long-Term Assets	3,550	3,595	3,668	9,006	1,636	1,427
Total Assets	75,406	99,816	75,938	95,508	48,505	27,088
Accounts Payable	148.68	13.31	14.49	-	3.09	66.98
Accrued Expenses	-	362.23	118.06	106.61	110.73	72.81
Short-Term Debt	22,240	28,299	13,848	-	-	-
Current Portion of Leases	624.02	1,019	516.4	826.8	446.97	475.1
Current Unearned Revenue	-	149.35	94.74	-	41.34	63.01
Other Current Liabilities	13,429	21,106	14,511	737.73	607.22	221.6
Total Current Liabilities	36,442	50,949	29,102	1,671	1,209	899.5
Long-Term Debt	16,200	16,200	6,200	13,727	-	-
Long-Term Leases	198	503.38	512.65	646.8	497.87	649.92
Other Long-Term Liabilities	926.99	966.07	859.83	27,030	506.05	465.83
Total Liabilities	54,050	68,619	36,675	43,075	2,453	2,330
Common Stock	10,773	10,762	10,597	5,170	4,215	4,174
Additional Paid-In Capital	145,367	145,327	143,454	142,580	65,668	39,913
Retained Earnings	-144,010	-130,518	-116,847	-106,702	-25,657	-20,049
Comprehensive Income & Other	6,225	5,627	2,059	1,059	829.8	718.91
Total Common Equity	18,356	31,197	39,263	42,107	45,056	24,757
Shareholders' Equity	21,356	31,197	39,263	52,433	46,052	24,757
Total Liabilities & Equity	75,406	99,816	75,938	95,508	48,505	27,088
Total Debt	39,262	46,021	21,077	15,201	944.84	1,125
Net Cash (Debt)	-16,029	5,725	19,347	42,965	35,934	20,599
Net Cash Growth	-	-70.41%	-54.97%	19.57%	74.45%	-28.55%
Net Cash Per Share	-746.86	270.01	928.31	2415.96	4289.45	2481.32
Filing Date Shares Outstanding	21.55	21.52	21.19	20.68	16.86	16.7
Total Common Shares Outstanding	21.55	21.52	21.19	20.68	16.86	16.7
Working Capital	-3,022	6,609	17,732	69,635	41,625	21,978
Book Value Per Share	851.92	1449.43	1852.51	2036.13	2672.07	1482.88
Tangible Book Value	17,437	30,366	38,413	41,303	44,336	24,424
Tangible Book Value Per Share	809.26	1410.81	1812.39	1997.25	2629.39	1462.91
Land	9,745	9,745	7,511	7,511	-	-
Buildings	8,038	4,072	-	-	-	-
Machinery	3,275	4,535	2,968	2,630	1,896	1,011
Construction In Progress	10,718	-	10,475	169.1	39.94	-

Source: S&P Capital IQ. Standard template. Financial Sources.